The DEA’s Cannabis Reclassification: A Shift in Federal Drug Policy and Its Broader Implications

a wooden judge's hammer sitting on top of a table

The U.S. Drug Enforcement Administration’s (DEA) recent proposal to reclassify “botanical cannabis” from Schedule I to Schedule III marks a pivotal shift in federal drug policy, one that reflects an evolving understanding of cannabis’s medical benefits and lower abuse potential. This historic move, catalyzed by recommendations from the Department of Health and Human Services (HHS) […]

zone vapor logo

Are you over 21 years of age?